Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (47)

2023

  1. Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 247-262

  2. Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage

    Frontiers in Cellular Neuroscience, Vol. 16

  3. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

  4. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2021

  1. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44

  2. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

2020

  1. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

    Lupus, Vol. 29, Núm. 1, pp. 27-36

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  3. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  4. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

  5. Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country

    BMC Rheumatology, Vol. 4, Núm. 1

  6. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161

2019

  1. Abnormalities in glucose metabolism, appetite-related peptide release, and pro-inflammatory cytokines play a central role in appetite disorders in peritoneal dialysis

    Frontiers in Physiology, Vol. 10, Núm. MAY

  2. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases

    Clinical Reviews in Allergy and Immunology, Vol. 56, Núm. 3, pp. 278-292

2018

  1. Inflammatory arthritis and heart disease

    Current Pharmaceutical Design, Vol. 24, Núm. 3, pp. 262-280

  2. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach

    International Journal of COPD, Vol. 13, pp. 591-601

2017

  1. Asthma-COPD overlap is not a homogeneous disorder: Further supporting data

    Respiratory Research

  2. Microbiota intestinal en la enfermedad renal crónica

    Nefrologia

  3. Quality indicators of asthma care derived from the spanish guidelines for asthma management (GEMA 4.0): A multidisciplinary team report

    Journal of Investigational Allergology and Clinical Immunology